Paper6696771
Human aldehyde dehydrogenase: catalytic activity in oriental liver.
Ferencz-Biro K and 1 other. Biochem Biophys Res Commun, 1984. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Human aldehyde dehydrogenase: catalytic activity in oriental liver. Papers, record 6696771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6696771
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldehyde Oxidoreductases | Major topic |
| Isoenzymes | Major topic |
| Mitochondria, Liver | Major topic |
| Mutation | Major topic |
| Aldehyde Dehydrogenase | |
| Asian People | |
| Humans | |
| White People |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AA00046 | NIAAA NIH HHS | United States | PubMed | |
| AA00186 | NIAAA NIH HHS | United States | PubMed |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34221859 | The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/34221859 | PubMed |
| 25713355 | Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25713355 | PubMed |
| 24382882 | Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. | Physiol Rev | 2014 | https://conductscience.org/library/papers/24382882 | PubMed |
| 16440063 | Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. | J Clin Invest | 2006 | https://conductscience.org/library/papers/16440063 | PubMed |
| 8903321 | The mutation in the mitochondrial aldehyde dehydrogenase (ALDH2) gene responsible for alcohol-induced flushing increases turnover of the enzyme tetramers in a dominant fashion. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8903321 | PubMed |
| 7593603 | The aldehyde dehydrogenase ALDH2*2 allele exhibits dominance over ALDH2*1 in transduced HeLa cells. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7593603 | PubMed |
| 4052009 | Enzymatic activity of atypical Oriental types of aldehyde dehydrogenases. | Biochem Genet | 1985 | https://conductscience.org/library/papers/4052009 | PubMed |
| 2562960 | Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2562960 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6696771
GET https://conductscience.org/api/papers/v1/6696771/authors